TJBH — Tengjun Biotechnology Balance Sheet
0.000.00%
Consumer CyclicalsSpeculativeMicro Cap
Annual balance sheet for Tengjun Biotechnology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0 | 0 | 0.006 | 0.286 | 2.83 |
| Net Total Receivables | — | — | — | — | 4.53 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 0.004 | 0.004 | 0.01 | 4.63 | 50.6 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | — | — | — | 9.4 | 8.06 |
| Total Assets | 0.004 | 0.004 | 0.01 | 14 | 58.6 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.249 | 0.284 | 0.293 | 16.3 | 43.7 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Liabilities | 0.249 | 0.284 | 0.293 | 16.2 | 44.2 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -0.245 | -0.28 | -0.282 | -2.19 | 14.5 |
| Total Liabilities & Shareholders' Equity | 0.004 | 0.004 | 0.01 | 14 | 58.6 |
| Total Common Shares Outstanding |